---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018499"
form_type: "8-K/A"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:56:57.497601+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs corrects Q1 EPS to $(0.35) from $(0.07); net loss $6.3M on revenue decline

## Summary
- Corrected diluted EPS $(0.35) vs originally $(0.07); weighted average shares corrected to 18.0M from 90.4M.
- Q1 net loss of $6.3M vs net income of $0.6M a year ago; revenue fell 81% to $3.6M as COVID testing ended.
- Pharmaloz exploring potential sale or long-term capacity agreements; line two expected $40-$45M revenue capacity in Q3.
- BE-Smart esophageal cancer test on track for H2 2024 commercialization; launched AI initiative Project ZenQ-AI.
- Cash at April 30 was $4.6M; raised $2.5M via receivable securitization and collected $3.6M from partial investment sale.

## SEC filing metadata
- accession: 0001493152-24-018499
- form_type: 8-K/A
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315224018499/0001493152-24-018499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315224018499/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018499
- JSON: https://secwatch.observer/filing/0001493152-24-018499.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018499.txt

## Key facts
- Earnings Releases
  ProPhase Labs, Inc. reported financial results for the three months ended March 31, 2024.
  - Period: the three months ended March 31, 2024
  - Result: reported results
  source text: ProPhase Labs, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315224018499/0001493152-24-018499-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.